MedPath

The study on comparison between Hytrin Single therapy and Hinechol and Hytrin combined therapy with Lower urinary tract symptom

Not Applicable
Conditions
Diseases of The genitoruinary system
Registration Number
KCT0003670
Lead Sponsor
Dongguk University Ilsan Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
130
Inclusion Criteria

Those with maximum flow rate (Qmax) is less than 15.0mL/s and postvoid residual urine is more than 50mL due to benign prostatic hyperplasia

Exclusion Criteria

1) Those with complete spinal cord lesion
2) Those with complete urinary retention or with an indwelling catheter
3) Those with bladder outlet obstruction or prostatic cancer or who underwent prostatic surgery
4) Those with severe cardiovascular or hepatic disorder or orthostatic hypotension or severe renal dysfunction.
5) Those who are taking 5a-reductase inhibitor, cholinergics, anti-cholinergics, alpha antagonist or agonist, beta agonist
6) Those with asthma or Parkinson disease.
7) Those who are sensitive to cholinergics or alpha-blocker
8) Those who are judged to be improper for this clinical trial.

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
IPSS (International Prostate Symptom Score)
Secondary Outcome Measures
NameTimeMethod
Average flow rate;Postvoid Residual Urine Volume
© Copyright 2025. All Rights Reserved by MedPath